Body Spasms in a Woman With Thyroid Disease

2021 ◽  
pp. 116-117
Author(s):  
Andrew McKeon

A 46-year-old woman with a history of autoimmune Hashimoto thyroiditis sought care for a 6-month history of spasms affecting her back and bilateral proximal lower extremities. On examination, the patient appeared anxious, and her whole body seemed to stiffen when the examiner entered the room. Her cognitive, cranial nerve, and upper extremity examinations were normal, except for brisk deep tendon reflexes. Examination of the patient’s spine indicated hyperlordosis of the lumbar region. There was visible hypertrophy of the lumbar paraspinal muscles. When asked to walk, the patient took short, tentative steps, despite having normal strength in her lower extremities. Her lower extremity tone demonstrated diffuse rigidity. Cerebrospinal fluid evaluation showed isolated increased protein concentration. Autoantibody testing of the serum and cerebrospinal fluid showed markedly increased levels of glutamic acid decarboxylase 65-kDa isoform–immunoglobulin G antibody in serum and in cerebrospinal fluid. Neurophysiologic studies in a movement disorders laboratory indicated a nonhabituating, exaggerated, acoustic startle response. Stiff-person syndrome was diagnosed. The patient received diazepam for symptomatic relief. At her follow-up visit, the patient reported reduction in frequency and severity of spasms but persistent stiffness throughout the lower back and lower extremities. Intravenous immunoglobulin was. After 3 months, the patient reported a 50% further improvement in stiffness and spasms but still required a walking aid. Physical therapy sessions focused on gait and safety, the patient was able to resume ambulation with a cane, without further falls. Stiff-person syndrome was described by Moersch and Woltman at Mayo Clinic in 1956. It most commonly arises in women of middle age but can affect men, women, and children. It is an autoimmune disorder of brainstem and spinal cord inhibitory interneuronal pathways, leading to what is termed central hyperexcitability.

2019 ◽  
Vol 90 (e7) ◽  
pp. A24.1-A24
Author(s):  
Shoaib Dal ◽  
Bill O’Brien

IntroductionAnti-glutamte decarboxylase antibody (anti-GAD) has been linked with various neurological syndromes including stiff-person syndrome, limbic encephalopathy, cerebellar ataxia, eye movement disorders and epilepsy (collectively known as ‘anti-GAD positive neurological syndromes’).1 We describe a very atypical phenotypic presentation of anti-GAD syndrome with unexplained vomiting and weight loss.CaseA 46 years old lady with no past medical or family history of note, presented with 6 months history of severe headaches and recurrent attacks of episodic vomiting (4–6 episodes of multiple vomiting daily) with no identified precipitant and complete normality in between the episodes with no other associated symptoms. She reported 15 kg of unintentional weight loss. Neurological examination and investigations including MRI brain, CT angiogram and liver enzymes, immunoglobulins, thyroid function, vasculitic screen were normal. Upper GI endoscopy, gastric emptying studies, CT imaging of chest, abdomen and pelvis and whole body PET scan were unremarkable. Serum autoimmune antibody screen was positive with high titre of anti-GAD antibody (1200 kU/liter). The cerebrospinal fluid anti-GAD antibody titre was raised at 103.7 kU/liter with otherwise normal parameters including negative oligoclonal bands. The nerve conduction studies did not show continuous motor activity or spasmodic reflex myoclonus (seen in stiff-person syndrome).2 A therapeutic trial of immunosuppression was introduced with moderate improvement in symptoms.ConclusionAnti-GAD neurological syndromes are rare and this is a unique presentation of the same. It is not completely understood why the presence of one antibody causes varied syndromes. The hypothesis is that the recurrent vomiting is possibly due to diaphragmatic spasms.ReferencesSaiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553–2563.Buechner S, Florio I, Capone L. Stiff person syndrome: A rare neurological disorder, heterogeneous in clinical presentation and not easy to treat. Case Rep Neurol Med2015; 2015:278065.


Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 35-35
Author(s):  
Minh Nguyen

Vitamin C plays an essential role in the formation of collagen. A deficiency in vitamin C can lead to scurvy, manifested by blood vessel fragility, fatigue, and, rarely, death. Today, scurvy is rare in developed countries. Therefore, to diagnose scurvy requires a high index of suspicion. This will be illustrated by our patient of interest. A 66-year-old man presented to the emergency department (ED) with worsening bilateral leg swelling and bruising throughout his body. His past medical history was notable for a bowel resection with colostomy secondary to colorectal cancer, currently in remission. The bruising and swelling began two weeks prior without any inciting events. He denied taking blood thinners or non-steroidal-anti-inflammatory-drugs. He had no personal or family history of bleeding disorders. None of his previous surgeries were complicated by bleeding issues. Extremities showed large ecchymoses over left thigh and bilateral ankles, and hematoma over right patella. There were no perifollicular hemorrhages seen on skin examination. His hemoglobin was 13.5 g/dL and his platelet count was 145x109/L. A computed tomography angiography of his lower extremities revealed intramuscular hematomas in the calves, left adductor compartment and left sartorius. A venous ultrasound of bilateral lower extremities was unremarkable. He was advised to follow up with a hematologist outpatient. Ten days later, the patient reported worsening swelling and pain of his lower extremities and was advised to visit the ED (FIGURE 1A). His Hgb dropped to 10.8 g/dL. An extensive factor workup showed: factor VIII activity of 421.7% (ref range: 55-200), factor IX activity of 104% (ref range: 70-130), factor XI activity of 68% (ref range: 55-150), and von Willebrand factor activity of 355% (ref range: 55-200). Factor V, X and XIII were within normal limits. Other possible etiologies including vitamin K, HIV, hepatitis panel, antinuclear antibody and extractable nuclear antigen antibodies panel were normal. His activated partial thromboplastin time (aPTT) was prolonged at 44 seconds (ref range 25-37). The dilute Russel's viper venom time (dRVVT) was abnormal and his dRVVT/dRVVT-phospholipid ratio was greater than 1.3 or greater, indicative of a lupus anticoagulant. Beta-2 glycoprotein 1 antibodies and anticardiolipin antibodies were normal. Bleeding due to prothrombin (factor II) deficiency in the context of lupus anticoagulant has been reported (2). However, his factor II level was normal. Meanwhile, his Hgb fell to 6.9 g/dL, indicative of ongoing intramuscular bleeding. Upon further investigation by the consulting hematology team and registered dietitian, there was a concern for severe malnutrition, evident by substantial loss of subcutaneous fat and muscle mass. The patient revealed that he consumed six twelve-ounce cans of beers nightly. His diet was minimal in fruits and vegetables. One month prior to his admission, he had worsening fatigue, brittle nails and gum bleeding. His folate level was 2.0 ng/mL (ref range >3.9) and his albumin level dropped to 2.1 g/dL (ref range 3.5-5). His vitamin C level resulted < 0.1 mg/dL (ref range 0.4-2). He was started on three days of intravenous vitamin C, one gram per day. His hematoma and bruises dramatically improved (FIGURE 1B). As a result, a diagnosis of scurvy was made. On discharge, he was transitioned to oral vitamin C and advised to follow up with his hematologist outpatient. Scurvy is often viewed as a disease of the past. Yet, according to a national survey between 2003 and 2004, the prevalence of age-adjusted vitamin C deficiency is 7%. At risk patients include the elderly, institutionalized populations, alcoholics, and severe psychiatric illness leading to poor nutritional intake. Therefore, a dietary history of the patient should be obtained. Vitamin C contributes to the structure of blood vessels through its involvement in collagen synthesis. Characteristic signs and symptoms of scurvy feature fatigue, oral findings (spontaneous bleeding, gum retraction) and cutaneous abnormalities (petechiae and lesions). Rarely, it can lead to spontaneous intramuscular hematoma. The prognosis of scurvy is excellent, and the response to vitamin C is dramatic. This case illustrates the need to consider scurvy in diagnosing bleeding cases. A high index of suspicion remains integral in diagnosing scurvy to avoid expensive and lengthy workup. Disclosures No relevant conflicts of interest to declare.


2015 ◽  
Vol 86 (11) ◽  
pp. e4.125-e4
Author(s):  
Maruthi Ravi Vinjam ◽  
Priya Shanmugarajan ◽  
Helen Ford

A 47-year previously fit and well lady presented with 6 weeks history of generalised lethargy, weight loss and neck pain. Her examination revealed left supra-clavicular lymph nodes. Subsequent investigations revealed left grade 2 invasive ductal carcinoma of her left breast. This was treated with local excision.She presented to hospital four weeks following her surgery with progressive double vision and unsteadiness. Her cranial nerve examination showed severly restricted pursuit and saccadic horizontal eye movements with intact vertical eye movements. She had normal strength with intact deep tendon reflexes with plantar flexor response. Her MRI head and spine with contrast and CSF examination, including cytology was normal.Two weeks into her admission she progressively developed generalised stiffness and severe axial and peripheral rigidity which was made worse with touch or emotions. These symptoms responded to benzodiazepines and baclofen. Her anti-amphiphysin antibodies were positive confirming the diagnosis of stiff person syndrome.Her breast cancer was treated aggressively with chemotherapy. Her stiffness and rigidity improved briefly following her chemotherapy. Eye movement's problems were described in anti-GAD related stiff person syndrome, which is due to GABA depletion. This is first ever-reported case where eye movement problem (Stiff eyes) is the initial presentation of a anti-amphiphysin antibody related stiff person syndrome.


Author(s):  
Sana Basseri ◽  
John P. Rossiter ◽  
M. Christopher Wallace ◽  
Omar Islam ◽  
Donatella Tampieri ◽  
...  

A previously healthy 48-year-old female presented to the emergency department with a 2-week history of low back pain, progressive lower extremities weakness, and right leg numbness. There were no bowel or bladder dysfunction symptoms. Spine magnetic resonance imaging (MRI) showed an intradural cystic lesion dorsal to the spinal cord at the level of L1 measuring 1.6 × 2.1 × 4.1 cm, which was T1 hypointense and T2 hyperintense, with a small soft tissue component and no gadolinium enhancement (Figure 1). A small lipomatous component was also noted. There were no associated vertebral anomalies. The patient underwent a T12-L2 laminectomy and cyst resection, which was subtotal due to the cyst adherence to the conus medullaris. Histopathology showed characteristic features of a neurenteric cyst, with respiratory-type epithelium in the cyst wall (Figure 2). Eight months later, follow-up MRI showed no evidence of recurrence. The patient reported improved sensation in the lower extremities; however, there was some residual weakness predominantly in the proximal hip flexors bilaterally.


2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Jared Hicken ◽  
Daniel Ramirez ◽  
Mark Rigby ◽  
Aram Minasian

Stiff-person syndrome (SPS) is a rare disorder seen in approximately one in one million people. Although it is rare, the symptoms and findings of a typical case should paint a clear clinical picture for those who are familiar with the disease. The primary findings in SPS include progressive axial muscle rigidity as well as muscle spasms. These symptoms most commonly occur in the setting of antibodies against Glutamic Acid Decarboxylase (GAD), the rate-limiting enzyme in the production of Gamma-Aminobutyric Acid (GABA), which is the primary inhibitory enzyme in the central nervous system. Here, we report the case of a 65-year-old African-American female with a past medical history of hypothyroidism, anxiety, and depression with psychotic features who presented with axial muscle rigidity and lactic acidosis. She had been symptomatic for several months and reported extensive workups performed at two previous hospitals without a definitive diagnosis. A complete neurological and musculoskeletal investigation yielded no positive findings except for the presence of GAD antibodies. The patient was treated with diazepam, tizanidine, and Intravenous Immunoglobulin (IVIG) with significant improvement, thus solidifying the diagnosis of SPS, a rare autoimmune and/or paraneoplastic syndrome.


2022 ◽  
Vol 2022 ◽  
pp. 1-5
Author(s):  
Ruchi Yadav ◽  
Neeraj Abrol ◽  
Sima Terebelo

Stiff person syndrome (SPS) is a rare autoimmune disease caused by lack of inhibition to excitatory neurotransmitters in the central nervous system (CNS) leading to inappropriate motor unit firing. The pathophysiology is incompletely understood; however, high titers of antiglutamic acid decarboxylase antibody (anti-GAD Ab) are strongly associated with this disease. We present a 50-year-old woman with a history of ongoing gait and balance issues for 5 years with multiple negative workups. She recently had an acute exacerbation which left her bedbound, unable to move her legs or turn from side to side. After a negative workup at an outside hospital, the patient was discharged to a subacute rehabilitation facility. She then presented to our institution due to worsening of her condition and was ultimately diagnosed with SPS which was successfully treated. We review the case presentation and treatment options in the context of a severe disabling disease presentation.


2021 ◽  
pp. 118-119
Author(s):  
Michelle F. Devine ◽  
A. Sebastian Lopez Chiriboga

A 41-year-old man sought care for 3 years of right-sided muscle stiffness. He also had 5- to 10-minute episodes of severe muscle spasms. He noted development of daily episodes of sudden, severe stiffness, often triggered by unexpected stimuli (eg, a touch or loud sound). He started using a walker and stopped driving. He stopped working because of increasing difficulty with mobility and cognition. On neurologic examination, he had a Kokmen Short Test of Mental Status score of 28/38, with points lost for orientation, attention, calculation, and recall. Cranial nerve examination showed bilateral ptosis and hypometric saccadic eye movements. He had normal strength but diffuse rigidity with increased tone, most severe in the right lower extremity. Magnetic resonance imaging of the brain indicated right parietal postoperative changes (post hematoma evacuation). Electroencephalography showed dysrhythmia grade 1 over the right frontotemporal region (above the prior hematoma). Cerebrospinal fluid was inflammatory, with mildly increased protein concentration and supernumerary oligoclonal bands. Movement laboratory evaluation demonstrated an exaggerated startle and abnormal exteroceptive response consistent with central nervous system hyperexcitability. Neural-specific autoantibody testing was positive for glycine receptor α‎1 subunit-immunoglobulin G in both serum and cerebrospinal fluid. He was diagnosed with progressive encephalomyelitis with rigidity and myoclonus with positive glycine receptor α‎1 subunit-immunoglobulin G. Given the immune-mediated cause of progressive encephalomyelitis with rigidity and myoclonus, he was started on intravenous methylprednisolone and concurrent rituximab. The patient markedly improved. His anxiety was still severe, however, and required increased escitalopram and cognitive behavioral therapy to control. He was tapered off intravenous methylprednisolone and maintained on rituximab. His symptoms eventually resolved. He remained stable at 2-year follow-up after initiating immunosuppression. Progressive encephalomyelitis with rigidity and myoclonus is considered a variant of stiff-person syndrome. There is clinical overlap between progressive encephalomyelitis with rigidity and myoclonus and classic stiff-person syndrome, which are both characterized by central nervous system hyperexcitability with exaggerated startle, muscle rigidity, and painful spasms.


2017 ◽  
Vol 1 (3) ◽  
pp. 156-160
Author(s):  
Jacqueline Watchmaker ◽  
Sean Legler ◽  
Dianne De Leon ◽  
Vanessa Pascoe ◽  
Robert Stavert

Background: Although considered a tropical disease, strongyloidiasis may be encountered in non-endemic regions, primarily amongst immigrants and travelers from endemic areas.  Chronic strongyloides infection may be under-detected owing to its non-specific cutaneous presentation and the low sensitivity of commonly used screening tools. Methods: 18 consecutive patients with serologic evidence of strongyloides infestation who presented to a single urban, academic dermatology clinic between September 2013 and October 2016 were retrospectively included.  Patient age, sex, country of origin, strongyloides serology titer, absolute eosinophil count, presenting cutaneous manifestations, and patient reported subjective outcome of pruritus after treatment were obtained via chart review.  Results: Of the 18 patients, all had non-specific pruritic dermatoses, 36% had documented eosinophila and none were originally from the United States. A majority reported subjective improvement in their symptoms after treatment. Conclusion:  Strongyloides infection and serologic testing should be considered in patients living in non-endemic regions presenting with pruritic dermatoses and with a history of exposure to an endemic area.Key Points:Chronic strongyloidiasis can be encountered in non-endemic areas and clinical manifestations are variableEosinophilia was not a reliable indicator of chronic infection in this case series Dermatologists should consider serologic testing for strongyloidiasis in patients with a history of exposure and unexplained pruritus


Sign in / Sign up

Export Citation Format

Share Document